{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:34:32Z","timestamp":1791837272168,"version":"4.3.4"},"reference-count":166,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903961"],"award-info":[{"award-number":["81903961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["19ZR1424000"],"award-info":[{"award-number":["19ZR1424000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["A3-2601-24-311001-5"],"award-info":[{"award-number":["A3-2601-24-311001-5"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Shanghai","award":["81903961"],"award-info":[{"award-number":["81903961"]}]},{"name":"Natural Science Foundation of Shanghai","award":["19ZR1424000"],"award-info":[{"award-number":["19ZR1424000"]}]},{"name":"Natural Science Foundation of Shanghai","award":["A3-2601-24-311001-5"],"award-info":[{"award-number":["A3-2601-24-311001-5"]}]},{"name":"Climbing Program of Shanghai University of Medicine and Health Sciences","award":["81903961"],"award-info":[{"award-number":["81903961"]}]},{"name":"Climbing Program of Shanghai University of Medicine and Health Sciences","award":["19ZR1424000"],"award-info":[{"award-number":["19ZR1424000"]}]},{"name":"Climbing Program of Shanghai University of Medicine and Health Sciences","award":["A3-2601-24-311001-5"],"award-info":[{"award-number":["A3-2601-24-311001-5"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of fatty liver disease, presents a significant global health challenge. Despite extensive research, fully elucidating its complex pathogenesis and developing accurate non-invasive diagnostic tools remain key goals. Multi-omics approaches, integrating data from transcriptomics, proteomics, metabolomics, and lipidomics, offer a powerful strategy to achieve these aims. This review summarizes key findings from multi-omics studies in MASH, highlighting their contributions to our understanding of disease mechanisms and the development of improved diagnostic models. Transcriptomic studies have revealed widespread gene dysregulation affecting lipid metabolism, inflammation, and fibrosis, while proteomics has identified altered protein expression patterns and potential biomarkers. Metabolomic and lipidomic analyses have further uncovered significant changes in various metabolites and lipid species, including ceramides, sphingomyelins, phospholipids, and bile acids, underscoring the central role of lipid dysregulation in MASH. These multi-omics findings have been leveraged to develop novel diagnostic models, some incorporating machine learning algorithms, with improved accuracy compared to traditional methods. Further research is needed to validate these findings, explore the complex interplay between different omics layers, and translate these discoveries into clinically useful tools for improved MASH diagnosis and prognosis.<\/jats:p>","DOI":"10.3390\/genes16040399","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:10:07Z","timestamp":1743397807000},"page":"399","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3792-3303","authenticated-orcid":false,"given":"Yilong","family":"Chen","sequence":"first","affiliation":[{"name":"School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China"},{"name":"Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuixiu","family":"Bian","sequence":"additional","affiliation":[{"name":"School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China"},{"name":"Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4776-1347","authenticated-orcid":false,"given":"Jiamei","family":"Le","sequence":"additional","affiliation":[{"name":"School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China"},{"name":"Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_2","first-page":"1999","article-title":"The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"31","author":"Younossi","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","first-page":"1061","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"2024","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ueg2.12556","article-title":"Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease?","volume":"12","author":"Tulone","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_6","first-page":"e16127","article-title":"Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients with MASLD: A Systematic Review","volume":"45","author":"Cathcart","year":"2024","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12072-024-10661-x","article-title":"MAFLD in adults: Non-invasive tests for diagnosis and monitoring of MAFLD","volume":"18","author":"Chan","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20420188221139614","DOI":"10.1177\/20420188221139614","article-title":"Non-invasive assessment of metabolic dysfunction-associated fatty liver disease","volume":"13","author":"Skantha","year":"2022","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hayes, C.N., Nakahara, H., Ono, A., Tsuge, M., and Oka, S. (2024). From Omics to Multi-Omics: A Review of Advantages and Tradeoffs. Genes, 15.","DOI":"10.20944\/preprints202411.0882.v1"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Reel, P.S., Reel, S., Pearson, E., Trucco, E., and Jefferson, E. (2021). Using machine learning approaches for multi-omics data analysis: A review. Biotechnol. Adv., 49.","DOI":"10.1016\/j.biotechadv.2021.107739"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"154320","DOI":"10.1016\/j.metabol.2020.154320","article-title":"The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease","volume":"111","author":"Perakakis","year":"2020","journal-title":"Metab. Clin. Exp."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e0310","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Caligiuri, A., Gentilini, A., and Marra, F. (2016). Molecular Pathogenesis of NASH. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091575"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: A pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3748\/wjg.v20.i7.1768","article-title":"Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3109\/10715762.2015.1078461","article-title":"Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease","volume":"49","author":"Ashraf","year":"2015","journal-title":"Free Radic. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1665-2681(19)31247-5","article-title":"Kupffer cells: Increasingly significant role in nonalcoholic fatty liver disease","volume":"13","author":"Wenfeng","year":"2014","journal-title":"Ann. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-\u03b2 in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Rajapaksha, I.G., Gunarathne, L.S., Angus, P.W., and Herath, C.B. (2021). Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040702"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.peptides.2014.10.005","article-title":"The role of renin-angiotensin system modulation on treatment and prevention of liver diseases","volume":"62","author":"Feltenberger","year":"2014","journal-title":"Peptides"},{"key":"ref_27","first-page":"1","article-title":"Transcriptome analysis","volume":"127","author":"Stahl","year":"2012","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s12276-024-01213-2","article-title":"Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41590-022-01365-1","article-title":"Ammonia detoxification promotes CD8(+) T cell memory development by urea and citrulline cycles","volume":"24","author":"Tang","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/gutjnl-2019-319226","article-title":"Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker","volume":"69","author":"Baselli","year":"2020","journal-title":"Gut"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/hep.31202","article-title":"Cardiolipin Synthase 1 Ameliorates NASH Through Activating Transcription Factor 3 Transcriptional Inactivation","volume":"72","author":"Tu","year":"2020","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101016","DOI":"10.1016\/j.xcrm.2023.101016","article-title":"Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH","volume":"4","author":"Conway","year":"2023","journal-title":"Cell Reports. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Huang, S., Sun, C., Hou, Y., Tang, Y., Zhu, Z., Zhang, Z., Zhang, Y., Wang, L., Zhao, Q., and Chen, M.G. (2018). A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-25658-4"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/hep.31995","article-title":"Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis","volume":"74","author":"Kozumi","year":"2021","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1478-3231.2005.01117.x","article-title":"Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis","volume":"25","author":"Younossi","year":"2005","journal-title":"Liver Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.32148","article-title":"Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e92264","DOI":"10.1172\/jci.insight.92264","article-title":"Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPAR\u03b1-regulated dermatopontin","volume":"2","author":"Lefebvre","year":"2017","journal-title":"JCI Insight"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2024.03.014","article-title":"Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis","volume":"81","author":"Yashaswini","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cmet.2024.05.008","article-title":"Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2023.11.001","article-title":"Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module","volume":"80","author":"Bendixen","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115310","DOI":"10.1016\/j.celrep.2025.115310","article-title":"Lipid droplet efferocytosis attenuates proinflammatory signaling in macrophages via TREM2- and MS4A7-dependent mechanisms","volume":"44","author":"Zhou","year":"2025","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2022.06.004","article-title":"Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH","volume":"77","author":"Hendrikx","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eadk1866","DOI":"10.1126\/scitranslmed.adk1866","article-title":"Hepatic danger signaling triggers TREM2+ macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation","volume":"16","author":"Zhou","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.31743","article-title":"Heterogeneity of HSCs in a Mouse Model of NASH","volume":"74","author":"Rosenthal","year":"2021","journal-title":"Hepatology"},{"key":"ref_47","first-page":"100278","article-title":"Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity","volume":"3","author":"Payen","year":"2021","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","article-title":"CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease","volume":"318","author":"Breuer","year":"2020","journal-title":"Am. J. Physiology. Gastrointest. Liver Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Carter, J.K., and Friedman, S.L. (2022). Hepatic Stellate Cell-Immune Interactions in NASH. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.867940"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-024-07465-2","article-title":"Acquisition of epithelial plasticity in human chronic liver disease","volume":"630","author":"Gribben","year":"2024","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","article-title":"Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy","volume":"11","author":"Jin","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Lee, A.T., Yang, M.Y., Lee, Y.J., Yang, T.W., Wang, C.C., and Wang, C.J. (2021). Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db\/db Mice. Antioxidants, 11.","DOI":"10.3390\/antiox11010092"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e168476","DOI":"10.1172\/jci.insight.168476","article-title":"miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression","volume":"9","author":"Cardelo","year":"2024","journal-title":"JCI Insight"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Panella, R., Petri, A., Desai, B.N., Fagoonee, S., Cotton, C.A., Nguyen, P.K., Lundin, E.M., Wagshal, A., Wang, D.Z., and N\u00e4\u00e4r, A.M. (2023). MicroRNA-22 Is a Key Regulator of Lipid and Metabolic Homeostasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612870"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/oby.23884","article-title":"MiR-484 promotes nonalcoholic fatty liver disease progression in mice via downregulation of Sorbs2","volume":"31","author":"Jia","year":"2023","journal-title":"Obesity"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep4.1501","article-title":"Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD","volume":"4","author":"Ezaz","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: From serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"152876","DOI":"10.1016\/j.prp.2020.152876","article-title":"miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1\/p53 signaling pathway","volume":"216","author":"Li","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbalip.2017.05.001","article-title":"Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease","volume":"1862","author":"Lin","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Cell Biol. Lipids"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1038\/cddis.2017.172","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jhep.2023.06.019","article-title":"Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2","volume":"79","author":"Li","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.7150\/ijbs.80760","article-title":"MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes","volume":"19","author":"Ma","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1080\/21655979.2021.2017698","article-title":"MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice","volume":"13","author":"Yu","year":"2022","journal-title":"Bioengineered"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"104597","DOI":"10.1016\/j.isci.2022.104597","article-title":"M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model","volume":"25","author":"Wan","year":"2022","journal-title":"iScience"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1080\/21691401.2019.1604536","article-title":"Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells","volume":"47","author":"Fu","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcb.26317","article-title":"Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR\/S6K1 signaling pathway","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"100584","DOI":"10.1016\/j.aohep.2021.100584","article-title":"Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p\/c-Jun\/SREBP-1c pathway","volume":"27","author":"Jin","year":"2022","journal-title":"Ann. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Xiang, J., Deng, Y.Y., Liu, H.X., and Pu, Y. (2022). LncRNA MALAT1 Promotes PPAR\u03b1\/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206\/ARNT Axis. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.858558"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.29654","article-title":"Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis","volume":"67","author":"Liu","year":"2018","journal-title":"Hepatology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41420-022-00889-7","article-title":"LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease","volume":"8","author":"Zou","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2019.01.018","article-title":"LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6","volume":"94","author":"Huang","year":"2019","journal-title":"Metab. Clin. Exp."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Erdem, M.G., Unlu, O., and Demirci, M. (2023). Could Long Non-Coding RNA MEG3 and PTENP1 Interact with miR-21 in the Pathogenesis of Non-Alcoholic Fatty Liver Disease?. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020574"},{"key":"ref_76","first-page":"1742","article-title":"Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity","volume":"39","author":"Scamporrino","year":"2019","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1080\/21655979.2022.2026858","article-title":"Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p\/NOTCH2 axis","volume":"13","author":"Cui","year":"2022","journal-title":"Bioengineered"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: A prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_80","first-page":"261","article-title":"Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review","volume":"41","author":"Lee","year":"2021","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3748\/wjg.v30.i18.2440","article-title":"FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis","volume":"30","author":"Yin","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e29860","DOI":"10.1016\/j.heliyon.2024.e29860","article-title":"Machine learning deciphers the significance of mitochondrial regulators on the diagnosis and subtype classification in non-alcoholic fatty liver disease","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/DMSO.S231321","article-title":"The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases","volume":"12","author":"Hendy","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Tan, Y., Ge, G., Pan, T., Wen, D., and Gan, J. (2014). A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105192"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.2147\/DMSO.S338097","article-title":"Effect of LncPVT1\/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD","volume":"14","author":"Zhang","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.3748\/wjg.v22.i44.9844","article-title":"Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population","volume":"22","author":"Liu","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.2147\/DMSO.S333431","article-title":"Upregulated lncRNA HCG18 in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin Resistance","volume":"14","author":"Xia","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Park, J.G., Kim, G., Jang, S.Y., Lee, Y.R., Lee, E., Lee, H.W., Han, M.H., Chun, J.M., Han, Y.S., and Yoon, J.S. (2020). Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis. Life, 10.","DOI":"10.3390\/life10100230"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Albadawy, R., Agwa, S.H.A., Khairy, E., Saad, M., El Touchy, N., Othman, M., and Matboli, M. (2021). Clinical Significance of HSPD1\/MMP14\/ITGB1\/miR-6881-5P\/Lnc-SPARCL1-1:2 RNA Panel in NAFLD\/NASH Diagnosis: Egyptian Pilot Study. Biomedicines, 9.","DOI":"10.3390\/biomedicines9091248"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12944-023-01988-9","article-title":"Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis","volume":"23","author":"Dai","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.2147\/JIR.S450471","article-title":"Identification of Mitophagy-Associated Genes for the Prediction of Metabolic Dysfunction-Associated Steatohepatitis Based on Interpretable Machine Learning Models","volume":"17","author":"Deng","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Cao, C., Liu, W., Guo, X., Weng, S., Chen, Y., Luo, Y., Wang, S., Zhu, B., Liu, Y., and Peng, D. (2024). Identification and validation of efferocytosis-related biomarkers for the diagnosis of metabolic dysfunction-associated steatohepatitis based on bioinformatics analysis and machine learning. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1460431"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Ouyang, G., Wu, Z., Liu, Z., Pan, G., Wang, Y., Liu, J., Guo, J., Liu, T., Huang, G., and Zeng, Y. (2023). Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1251750"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Qin, J., Cao, P., Ding, X., Zeng, Z., Deng, L., and Luo, L. (2023). Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1303426"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Fang, Z., Liu, C., Yu, X., Yang, K., Yu, T., Ji, Y., and Liu, C. (2024). Identification of neutrophil extracellular trap-related biomarkers in non-alcoholic fatty liver disease through machine learning and single-cell analysis. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-72151-2"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e33597","DOI":"10.1016\/j.heliyon.2024.e33597","article-title":"Key factor screening in mouse NASH model using single-cell sequencing combined with machine learning","volume":"10","author":"Song","year":"2024","journal-title":"Heliyon"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e0089","DOI":"10.1097\/HC9.0000000000000089","article-title":"miR-34a regulates macrophage-associated inflammation and angiogenesis in alcohol-induced liver injury","volume":"7","author":"Wan","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41435-023-00205-y","article-title":"Identification of heat shock protein family A member 5 (HSPA5) targets involved in nonalcoholic fatty liver disease","volume":"24","author":"Rehati","year":"2023","journal-title":"Genes. Immun."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Yokoyama, S., Muto, H., Honda, T., Kurokawa, Y., Ogawa, H., Nakajima, R., Kawashima, H., and Tani, H. (2024). Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168927"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"15451","DOI":"10.18632\/aging.205374","article-title":"Identification and validation of key biomarkers associated with macrophages in nonalcoholic fatty liver disease based on hdWGCNA and machine learning","volume":"15","author":"Li","year":"2023","journal-title":"Aging"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-0716-1024-4_8","article-title":"Quantitative Mass Spectrometry-Based Proteomics: An Overview","volume":"2228","author":"Rozanova","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Stiglund, N., Hagstr\u00f6m, H., St\u00e5l, P., Cornillet, M., and Bj\u00f6rkstr\u00f6m, N.K. (2023). Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1186097"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"101257","DOI":"10.1016\/j.xcrm.2023.101257","article-title":"Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese","volume":"4","author":"Jia","year":"2023","journal-title":"Cell Reports. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"eadh9940","DOI":"10.1126\/scitranslmed.adh9940","article-title":"Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population","volume":"16","author":"Ding","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_107","first-page":"887","article-title":"Distinct Immune Imprints of Post-Liver Transplantation Hepatitis C Persist Despite Viral Clearance","volume":"27","author":"Aregay","year":"2021","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"411","DOI":"10.31557\/APJCP.2023.24.2.411","article-title":"Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population","volume":"24","author":"Molaei","year":"2023","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Veyel, D., Wenger, K., Broermann, A., Bretschneider, T., Luippold, A.H., Krawczyk, B., Rist, W., and Simon, E. (2020). Biomarker discovery for chronic liver diseases by multi-omics\u2014A preclinical case study. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-58030-6"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","article-title":"A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat. Metab."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep4.1670","article-title":"SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH","volume":"5","author":"Luo","year":"2021","journal-title":"Hepatol. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Adamek, A., and Kasprzak, A. (2018). Insulin-Like Growth Factor (IGF) System in Liver Diseases. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051308"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Niu, L., Geyer, P.E., Wewer Albrechtsen, N.J., Gluud, L.L., Santos, A., Doll, S., Treit, P.V., Holst, J.J., Knop, F.K., and Vilsb\u00f8ll, T. (2019). Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol. Syst. Biol., 15.","DOI":"10.15252\/msb.20188793"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Wu, X., Xu, M., Yue, T., Ling, P., Fang, T., Luo, S., Xu, S., and Weng, J. (2022). Comparative Proteomic Analysis of Liver Tissues and Serum in db\/db Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179687"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Liu, T., Liu, D., Liu, R., Jiang, H., Yan, G., Li, W., Sun, L., Zhang, S., Liu, Y., and Guo, K. (2017). Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis. Sci. Rep., 7.","DOI":"10.1038\/srep38918"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Pyo, J.J., and Choi, Y. (2022). Key hepatic signatures of human and mouse nonalcoholic steatohepatitis: A transcriptome-proteome data meta-analysis. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.934847"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2021.09.008","article-title":"Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function","volume":"76","author":"Fondevila","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_120","first-page":"101073","article-title":"Glycogen synthase kinase 3 activity enhances liver inflammation in MASH","volume":"6","author":"Khoury","year":"2024","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","article-title":"Proteomics: Technologies and Their Applications","volume":"55","author":"Aslam","year":"2017","journal-title":"J. Chromatogr. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/gutjnl-2022-327498","article-title":"Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis","volume":"72","author":"Angelini","year":"2023","journal-title":"Gut"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.32620","article-title":"Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness","volume":"77","author":"Wernberg","year":"2023","journal-title":"Hepatology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e0265","DOI":"10.1097\/HC9.0000000000000265","article-title":"sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation","volume":"7","author":"Kothari","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e3230","DOI":"10.1210\/clinem\/dgac292","article-title":"Serum Thrombospondin-2 Levels Are Closely Associated With the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease","volume":"107","author":"Wu","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jhep.2022.11.029","article-title":"Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease","volume":"78","author":"Sanyal","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.09.026","article-title":"ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD","volume":"76","author":"Corey","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_128","first-page":"1234","article-title":"Novel urinary protein panels for the non-invasive diagnosis of non-alcoholic fatty liver disease and fibrosis stages","volume":"43","author":"Feng","year":"2023","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e202300236","DOI":"10.1002\/prca.202300236","article-title":"Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction-Associated Steatohepatitis","volume":"18","author":"Sourianarayanane","year":"2024","journal-title":"Proteomics. Clin. Appl."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Sydor, S., Dandyk, C., Schwerdt, J., Manka, P., Benndorf, D., Lehmann, T., Schallert, K., Wolf, M., Reichl, U., and Canbay, A. (2022). Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23168841"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and Metabolic Diseases: Where Do We Stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"100164","DOI":"10.1016\/j.jlr.2021.100164","article-title":"The foundations and development of lipidomics","volume":"63","author":"Han","year":"2022","journal-title":"J. Lipid Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41592-021-01198-0","article-title":"SpaceM reveals metabolic states of single cells","volume":"18","author":"Rappez","year":"2021","journal-title":"Nat. Methods"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1021\/acs.analchem.7b05215","article-title":"Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity","volume":"90","author":"Soons","year":"2018","journal-title":"Anal. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Stopka, S.A., van der Reest, J., Abdelmoula, W.M., Ruiz, D.F., Joshi, S., Ringel, A.E., Haigis, M.C., and Agar, N.Y.R. (2022). Spatially resolved characterization of tissue metabolic compartments in fasted and high-fat diet livers. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0261803"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-0716-2128-8_22","article-title":"Analysis of the Sphingolipidome in NAFLD","volume":"2455","author":"Montefusco","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e0523","DOI":"10.1097\/HC9.0000000000000523","article-title":"Sex- and age-associated factors drive the pathophysiology of MASLD","volume":"8","author":"Yadav","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Montandon, S.A., Somm, E., Loizides-Mangold, U., de Vito, C., Dibner, C., and Jornayvaz, F.R. (2019). Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-53346-4"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/MPG.0000000000003418","article-title":"Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study","volume":"74","author":"Mann","year":"2022","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1039\/D3FO05111K","article-title":"A CDAHFD-induced mouse model mimicking human NASH in the metabolism of hepatic phosphatidylcholines and acyl carnitines","volume":"15","author":"Yang","year":"2024","journal-title":"Food Funct."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Fitzinger, J., Rodriguez-Blanco, G., Herrmann, M., Borenich, A., Stauber, R., Aigner, E., and Mangge, H. (2024). Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease. Nutrients, 16.","DOI":"10.3390\/nu16020250"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1053\/j.gastro.2020.02.033","article-title":"TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits \u03b3-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice","volume":"158","author":"Zhao","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"121626","DOI":"10.1016\/j.lfs.2023.121626","article-title":"A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease","volume":"322","author":"Ganesan","year":"2023","journal-title":"Life Sci."},{"key":"ref_147","first-page":"100477","article-title":"Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease","volume":"4","author":"McGlinchey","year":"2022","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Gautam, J., Aggarwal, H., Kumari, D., Gupta, S.K., Kumar, Y., and Dikshit, M. (2024). A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL\/6J mouse. Biochim. Biophys. Acta. Mol. Cell Biol. Lipids, 1869.","DOI":"10.1016\/j.bbalip.2024.159545"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Fotakis, C., Kalafati, I.P., Amanatidou, A.I., Andreou, V., Matzapetakis, M., Kafyra, M., Varlamis, I., Zervou, M., and Dedoussis, G.V. (2023). Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1230457"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Yan, Y., Chen, Q., Xiang, Z., Wang, Q., Long, Z., Liang, H., Ameer, S., Zou, J., Dai, X., and Zhu, Z. (2024). Amino acid metabolomics and machine learning-driven assessment of future liver remnant growth after hepatectomy in livers of various backgrounds. J. Pharm. Biomed. Anal., 249.","DOI":"10.1016\/j.jpba.2024.116369"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/ac403931r","article-title":"Shotgun approach for quantitative imaging of phospholipids using nanospray desorption electrospray ionization mass spectrometry","volume":"86","author":"Lanekoff","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HEP.0000000000000542","article-title":"Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)","volume":"79","author":"Noureddin","year":"2024","journal-title":"Hepatology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ueg2.12589","article-title":"One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population","volume":"12","author":"Iruzubieta","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"100647","DOI":"10.1016\/j.jlr.2024.100647","article-title":"Novel eicosanoid signature in plasma provides diagnostic for metabolic dysfunction-associated steatotic liver disease","volume":"65","author":"Quehenberger","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/apt.16066","article-title":"Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease","volume":"52","author":"Jung","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Zhu, Q., Li, H., Ao, Z., Xu, H., Luo, J., Kaurich, C., Yang, R., Zhu, P.W., Chen, S.D., and Wang, X.D. (2022). Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis. J. Nanobiotechnol., 20.","DOI":"10.1186\/s12951-022-01540-4"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Mouskeftara, T., Kalopitas, G., Liapikos, T., Arvanitakis, K., Germanidis, G., and Gika, H. (2024). Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115965"},{"key":"ref_158","first-page":"1463","article-title":"Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/HEP.0000000000000474","article-title":"An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations","volume":"78","author":"Carr","year":"2023","journal-title":"Hepatology"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Ji, M., Jo, Y., Choi, S.J., Kim, S.M., Kim, K.K., Oh, B.C., Ryu, D., Paik, M.J., and Lee, D.H. (2022). Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071669"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"eabk0855","DOI":"10.1126\/scitranslmed.abk0855","article-title":"Risk assessment with gut microbiome and metabolite markers in NAFLD development","volume":"14","author":"Leung","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"100104","DOI":"10.1016\/j.jlr.2021.100104","article-title":"Nonalcoholic fatty liver disease stratification by liver lipidomics","volume":"62","author":"Vvedenskaya","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.hbpd.2021.05.008","article-title":"LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver","volume":"20","author":"Wang","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int. HBPD INT"},{"key":"ref_164","first-page":"149","article-title":"Metabolomics enables precision medicine: \u201cA White Paper, Community Perspective\u201d","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics Off. J. Metabolomic Soc."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.trac.2015.03.007","article-title":"Challenges and developments in protein identification using mass spectrometry","volume":"69","author":"Szabo","year":"2015","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhep.2024.03.035","article-title":"Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases","volume":"81","author":"Thiele","year":"2024","journal-title":"J. Hepatol."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/4\/399\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:05:42Z","timestamp":1760029542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/4\/399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":166,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["genes16040399"],"URL":"https:\/\/doi.org\/10.3390\/genes16040399","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]}}}